Simplex Trading’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
SM
VVM
TCM
Simplex Trading's TPST Position: Q2 2025 in Review
Simplex Trading sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 1,571 shares — an estimated $15K sold.
Simplex Trading first reported a position in TPST in Q1 2015 and held it in 14 quarters. The position peaked at $296K in Q4 2023. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.
- Simplex Trading reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 1,571 Tempest Therapeutics shares in Q2 2025, an estimated $15K.
- Simplex Trading first reported a position in Tempest Therapeutics in Q1 2015 and held it in 14 quarters.
- Simplex Trading's Tempest Therapeutics position peaked at $296K in Q4 2023.
- 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.